The comparison of soluble p-selectin, anti-platelet factor 4, and platelet maximum aggregation levels among coronavirus disease 2019 patients
INTRODUCTION: The coronavirus disease 2019 (COVID-19) continues to have an enormous and extensive effect on global health, causing widespread devastation. Patients who have recovered from COVID-19 have an increased risk of thromboembolic disease. We suggest that soluble P-selectin and anti-platelet factor 4 (anti-PF4) plays a significant role in platelet activation, ultimately resulting in thrombosis. The purpose of this study is to compare the role of soluble P-selectin, anti-PF4, and platelet maximal aggregation levels in COVID-19 patients. MATERIALS AND METHODS: A cross-sectional study was conducted among COVID-19 patients who were admitted to the hospital between October 2021 and January 2022. RESULTS: From 160 individuals, we found that a number of individuals with older age (P = 0.014) and lower hemoglobin levels (P = 0.042) were significantly higher in the severe COVID-19 group compared to the nonsevere COVID-19 group. Remarkably, soluble P-selectin levels in mild-to-moderate COVID-19 were found to be significantly higher than the severe group, with statistical significance (P = 0.02). However, there was no significant difference in anti-PF4 levels between severe and nonsevere COVID-19 groups. Furthermore, platelet maximum aggregation was also significantly higher in the severe COVID-19 group than in the mild-to-moderate COVID-19 group by using 2.5 μM (P = 0.024), 5 μM (P = 0.026), and 10 μM adenosine-diphosphate (P = 0.02). CONCLUSION: Soluble P-selectin, an indicator of platelet activation, was shown to be significantly higher in mild-to-moderate COVID-19 group than the severe COVID-19 group. The maximum aggregation of platelets was also observed to be significantly greater in the severe COVID-19 group..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of Applied Hematology - 14(2023), 4, Seite 274-280 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Andhika Rachman [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Anti-platelet factor 4 |
|---|
| doi: |
10.4103/joah.joah_77_23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ092425305 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ092425305 | ||
| 003 | DE-627 | ||
| 005 | 20240413182245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/joah.joah_77_23 |2 doi | |
| 035 | |a (DE-627)DOAJ092425305 | ||
| 035 | |a (DE-599)DOAJ96038372bd7e4da6935d6547884787da | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Andhika Rachman |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The comparison of soluble p-selectin, anti-platelet factor 4, and platelet maximum aggregation levels among coronavirus disease 2019 patients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a INTRODUCTION: The coronavirus disease 2019 (COVID-19) continues to have an enormous and extensive effect on global health, causing widespread devastation. Patients who have recovered from COVID-19 have an increased risk of thromboembolic disease. We suggest that soluble P-selectin and anti-platelet factor 4 (anti-PF4) plays a significant role in platelet activation, ultimately resulting in thrombosis. The purpose of this study is to compare the role of soluble P-selectin, anti-PF4, and platelet maximal aggregation levels in COVID-19 patients. MATERIALS AND METHODS: A cross-sectional study was conducted among COVID-19 patients who were admitted to the hospital between October 2021 and January 2022. RESULTS: From 160 individuals, we found that a number of individuals with older age (P = 0.014) and lower hemoglobin levels (P = 0.042) were significantly higher in the severe COVID-19 group compared to the nonsevere COVID-19 group. Remarkably, soluble P-selectin levels in mild-to-moderate COVID-19 were found to be significantly higher than the severe group, with statistical significance (P = 0.02). However, there was no significant difference in anti-PF4 levels between severe and nonsevere COVID-19 groups. Furthermore, platelet maximum aggregation was also significantly higher in the severe COVID-19 group than in the mild-to-moderate COVID-19 group by using 2.5 μM (P = 0.024), 5 μM (P = 0.026), and 10 μM adenosine-diphosphate (P = 0.02). CONCLUSION: Soluble P-selectin, an indicator of platelet activation, was shown to be significantly higher in mild-to-moderate COVID-19 group than the severe COVID-19 group. The maximum aggregation of platelets was also observed to be significantly greater in the severe COVID-19 group. | ||
| 650 | 4 | |a anti-platelet factor 4 | |
| 650 | 4 | |a coronavirus disease 2019 | |
| 650 | 4 | |a platelet aggregation | |
| 650 | 4 | |a soluble p-selectin | |
| 650 | 4 | |a thrombosis | |
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Rahmanu Reztaputra |e verfasserin |4 aut | |
| 700 | 0 | |a Adityo Susilo |e verfasserin |4 aut | |
| 700 | 0 | |a Pringgodigdo Nugroho |e verfasserin |4 aut | |
| 700 | 0 | |a Rachelle Betsy |e verfasserin |4 aut | |
| 700 | 0 | |a Samuel Juanputra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Applied Hematology |d Wolters Kluwer Medknow Publications, 2018 |g 14(2023), 4, Seite 274-280 |w (DE-627)DOAJ000048844 |x 24546976 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g number:4 |g pages:274-280 |
| 856 | 4 | 0 | |u https://doi.org/10.4103/joah.joah_77_23 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/96038372bd7e4da6935d6547884787da |z kostenfrei |
| 856 | 4 | 0 | |u http://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=4;spage=274;epage=280;aulast=Rachman |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1658-5127 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |e 4 |h 274-280 | ||